Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric Surgery

被引：0
|
作者：
Thom Kok
Hans de Boer
Bart Witteman
Marcel Hovens
Matthijs van Luin
Houshang Monajemi
机构：
[1] Rijnstate Hospital,Department of Internal Medicine
[2] Rijnstate Hospital,Department of Surgery
[3] University Medical Center Utrecht,Department of Clinical Pharmacy, Division of Laboratory Medicine and Pharmacy
[4] Utrecht University,undefined
来源：
Obesity Surgery | 2022年 / 32卷
关键词：
Apixaban; Rivaroxaban; Bariatric surgery; Morbid obesity; Anti-Xa level;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 614
页数：7
相关论文
共 50 条
  • [1] Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric Surgery
    Kok, Thom
    de Boer, Hans
    Witteman, Bart
    Hovens, Marcel
    van Luin, Matthijs
    Monajemi, Houshang
    [J]. OBESITY SURGERY, 2022, 32 (03) : 607 - 614
  • [2] Observed Apixaban Anti-Xa Levels in Obese Patients
    Harkness, Weston
    Pipitone, Olivia
    Joss, Jacqueline
    Schiedler, Michael
    Shagavah, Santon
    Moore, Ryan
    Hsing, Jeff
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1215 - 1221
  • [3] UTILITY OF APIXABAN OR RIVAROXABAN ANTI-XA LEVELS IN TRANSITIONING PATIENTS TO HEPARIN INFUSIONS
    Huang, Wan-Ting
    Nguyen, Kevin
    Patel, Aakash
    Lerner, Dmitri
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 447 - 447
  • [4] Comparison of Anti-Xa Activity in Patients Receiving Apixaban or Rivaroxaban
    Bookstaver, David A.
    Sparks, Kimberly
    Pybus, Brandon S.
    Davis, Dustin K.
    Marcsisin, Sean R.
    Sousa, Jason C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (03) : 251 - 256
  • [5] Achieving Therapeutic Anti-Xa Levels Using Rivaroxaban for Venous Thromboembolism in a Morbidly Obese Patient with a BMI >70
    Prakash, Swathi
    Dah, Kingsley
    Ghafouri, Sayed
    De la Rosa, Alan
    Porres-Aguilar, Mateo
    [J]. BLOOD, 2022, 140 : 11379 - 11380
  • [6] Effect of Prophylactic Dalteparin on Anti-factor Xa Levels in Morbidly Obese Patients After Bariatric Surgery
    Simoneau, Marie-David
    Vachon, Audrey
    Picard, Frederic
    [J]. OBESITY SURGERY, 2010, 20 (04) : 487 - 491
  • [7] Anti-Xa levels after a subcutaneous injection of 5700 IU nadroparin in morbidly obese patients
    Diepstraten, J.
    Janssen, E. J. H.
    Hackeng, C. M.
    van Kralingen, S.
    van Dongen, E. P. A.
    Wiezer, M. J.
    van Ramshorst, B.
    Knibbe, C. A. J.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 315 - 315
  • [8] Effect of Prophylactic Dalteparin on Anti-factor Xa Levels in Morbidly Obese Patients After Bariatric Surgery
    Marie-David Simoneau
    Audrey Vachon
    Frédéric Picard
    [J]. Obesity Surgery, 2010, 20 : 487 - 491
  • [9] Heparin interference in anti-XA assays for rivaroxaban and apixaban
    Cutsforth, G. A.
    Finnegan, K.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 795 - 795
  • [10] POPULATION PHARMACODYNAMICS OF NADROPARIN IN MORBIDLY OBESE PATIENTS USING ANTI-XA LEVELS AS PHARMACODYNAMIC ENDPOINT
    Diepstraten, J.
    Janssen, E. J.
    Hacking, C. M.
    van Kralingen, S.
    Peeters, M. Y.
    van Dongen, E. P.
    Wiezer, R. J.
    van Ramshorst, B.
    Knibbe, C. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S27 - S27
12345